Change to MMR and varicella vaccine supply under the NIP from 1 July 2025

Written By Cristy Houghton

The Department of Health, Disability and Ageing is advising general practitioners of an upcoming change to vaccine supply arrangements under the National Immunisation Program (NIP), effective 1 July 2025.

What’s changing?

From 1 July 2025, supply of measles-containing vaccines will transition from two suppliers (GSK and CSL) to a single supplier – GSK.

What this means for your practice

  • You will no longer be able to order CSL’s M-M-R® II (MMR) or Varivax (Varicella).

  • You will be able to order only GSK’s:

    • Priorix (MMR)

    • Priorix-Tetra (MMRV)

    • Varilrix (Varicella)

  • Continue to use your existing stock of M-M-R® II and Varivax until it is used up or expires.

No change to:

  • The current NIP vaccination schedule

  • The vaccine ordering process

To receive updates directly to your inbox, we encourage you to subscribe to the Department’s NIP email list.

Cristy Houghton
Previous

RSV maternal vaccine added to National Immunisation Program
Next

Accreditation practice pointer: members of our clinical team are qualified